HomeEverythingEducation
Equities & FundsCrypto & Digital AssetsAI & TechnologyBusiness & CorporateUS Politics & PolicyGeopolitics & Global RiskMacro, Rates & FXCommodities & EnergyEuropean Politics & MarketsAsia-PacificReal Estate & Property
Story archiveAll categories
← All Stories

Roth/MKM initiates Coya Therapeutics stock with buy rating

Created at 5 Jun · 7:28 AM1 source
IN SHORT

Roth/MKM has initiated coverage of Coya Therapeutics stock with a buy rating and set a target price for the company's shares.

✉Newsletter

PiQ Daily

Pick your topics. Get only what matters, on your cadence.

Who's Involved

Roth/MKM
Brokerage firm initiating coverage of Coya Therapeutics
Coya Therapeutics
Company whose stock is being initiated with a buy rating

↳ Why This Matters

Analyst initiation with a buy rating and price target can influence investor sentiment and potentially impact Coya Therapeutics' stock price.

Key facts

  • Roth/MKM initiated coverage of Coya Therapeutics stock.
  • Roth/MKM assigned a buy rating to Coya Therapeutics stock.
  • Roth/MKM set a target price for Coya Therapeutics shares.

Roth/MKM has begun covering Coya Therapeutics, assigning a 'buy' rating to the company's stock. The brokerage firm also established a specific price target for Coya Therapeutics' shares, indicating a positive outlook on the company's future performance.

Frequently asked questions

Coya Therapeutics is a company whose stock has been initiated with a buy rating by Roth/MKM.

Roth/MKM initiated coverage with a buy rating.

Yes, Roth/MKM set a target price for Coya Therapeutics' shares.

Get the newsletter.

Pick the topics you actually care about. We'll email when there's news worth your time, on the cadence you choose. Cancel any time from your account.

Cadence
CME Headlines
  • New Product Summary: Initial Listing of Fifty-Five (55) Single Stock Futures Contracts — Effective July 27, 2026
    27 Jul · 4:32 PM
  • New Product Summary: Initial Listing of Twenty-Two (22) Micro Single Stock Futures Contracts - Effective July 27, 2026
    27 Jul · 4:11 PM
  • Initial Listing of Additional Event Contract Swaps on Pro Golf Tournaments
    9 Jul · 9:41 AM

How It Developed

5 Jun · 7:02 AM
Roth/MKM initiated coverage of Coya Therapeutics stock with a buy rating and set a target price.
Investing.com via PiQSuite

Sources

T1
Roth/MKM initiates Coya Therapeutics stock with buy ratingm.piqsuite.com

Related Stories

JPMorgan Hires Michael Flynn to Lead New Small-Cap Banking Business
8 Jul · 3:03 PM
Michael Burry Buys Flutter, DraftKings Shares on Prediction Market Threat
8 Jul · 9:51 PM
SpaceX Analyst Maintains Neutral Stance Amid Wall Street Buy Frenzy
8 Jul · 10:00 AM
Goldman Sachs forecasts 50% jump for CATL shares amid energy storage growth
9 Jul · 2:40 AM
Zhipu AI Shares Rise After Lockup Expiry Amid Investor Support
8 Jul · 8:25 PM